The Sodium Hyaluronate Injection, cataloged under National Stock Number 6505-01-594-6041, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Esoterix Genetic Laboratories Llc Div Integrated Genetics and Integrated Oncology Business Units. Government technical data includes 4 specifications, cited from the U.S. Government catalog. The record lists 5 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 2 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active.
| Parameter | Value |
|---|---|
| NSN | 6505-01-594-6041 |
| Primary Part Number | HYLAN G-F 20 6ML |
| Item Name | Sodium Hyaluronate Injection |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Esoterix Genetic Laboratories Llc Div Integrated Genetics and Integrated Oncology Business Units |
| Status | ACTIVE |
| Administration | INTRA-ARTICULAR |
| Primary Container Content Quantity | 10.0 MILLILITERS |
| Features Provided | STERILE |
| Primary Container Type | SYRINGE |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Part Number | Manufacturer |
|---|---|
| 3336625 | Sanofi-Aventis Holdings Ltd (GBR) |
| HYLAN G-F 20 6ML PRIMARY | Esoterix Genetic Laboratories Llc Div Integrated Genetics and Integrated Oncology Business Units (USA) |
| SYN0277M | Aah Pharmaceuticals Ltd (GBR) |
| SYNVISC-ONE | Sanofi-Aventis Holdings Ltd (GBR) |
| SYNVISC-ONE | Esoterix Genetic Laboratories Llc Div Integrated Genetics and Integrated Oncology Business Units (USA) |
| Reference | Meaning |
|---|---|
| HYLAN G-F 20 | 5/1 Secondary reference Sanofi-Aventis Holdings Ltd |
| HILANO G-F 20 | 5/9 Secondary reference Genzyme Do Brasil Ltda |
NSN 6505-01-594-6041 is a Sodium Hyaluronate Injection, manufactured by Esoterix Genetic Laboratories Llc Div Integrated Genetics and Integrated Oncology Business Units, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-594-6041 has 5 manufacturer part numbers on file: 3336625 (Sanofi-Aventis Holdings Ltd), HYLAN G-F 20 6ML (Esoterix Genetic Laboratories Llc Div Integrated Genetics and Integrated Oncology Business Units), SYN0277M (Aah Pharmaceuticals Ltd), SYNVISC-ONE (Sanofi-Aventis Holdings Ltd), SYNVISC-ONE (Esoterix Genetic Laboratories Llc Div Integrated Genetics and Integrated Oncology Business Units).
Key specifications for HYLAN G-F 20 6ML: Administration: INTRA-ARTICULAR; Primary Container Content Quantity: 10.0 MILLILITERS; Features Provided: STERILE; Primary Container Type: SYRINGE. 4 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.